A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets

Abstract Background Brain monoamine vesicular transport disease is an infantile onset neurodevelopmental disorder caused by variants in SLC18A2, which codes for the vesicular monoamine transporter 2 (VMAT2) protein, involved in the transport of monoamines into synaptic vesicles and of serotonin into...

Full description

Bibliographic Details
Main Authors: Manisha Padmakumar, Jaak Jaeken, Vincent Ramaekers, Lieven Lagae, Daniel Greene, Chantal Thys, Chris Van Geet, NIHR BioResource, Kathleen Stirrups, Kate Downes, Ernest Turro, Kathleen Freson
Format: Article
Language:English
Published: Wiley 2019-05-01
Series:JIMD Reports
Subjects:
Online Access:https://doi.org/10.1002/jmd2.12030
id doaj-fc61d66386ba4d82840c3f4a32dfd91f
record_format Article
spelling doaj-fc61d66386ba4d82840c3f4a32dfd91f2021-06-28T05:10:34ZengWileyJIMD Reports2192-83122019-05-0147191610.1002/jmd2.12030A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in plateletsManisha Padmakumar0Jaak Jaeken1Vincent Ramaekers2Lieven Lagae3Daniel Greene4Chantal Thys5Chris Van Geet6NIHR BioResource7Kathleen Stirrups8Kate Downes9Ernest Turro10Kathleen Freson11Department of Cardiovascular Sciences Centre for Molecular and Vascular Biology, KU Leuven Leuven BelgiumDepartment of Development and Regeneration, Pediatrics KU Leuven Leuven BelgiumDepartment of Neuropediatrics Centre Hospitalier Universitaire Notre‐Dame des Bruyères Liége BelgiumDepartment of Development and Regeneration, Pediatrics KU Leuven Leuven BelgiumNIHR BioResource – Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus Cambridge UKDepartment of Cardiovascular Sciences Centre for Molecular and Vascular Biology, KU Leuven Leuven BelgiumDepartment of Cardiovascular Sciences Centre for Molecular and Vascular Biology, KU Leuven Leuven BelgiumNIHR BioResource – Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus Cambridge UKNIHR BioResource – Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus Cambridge UKDepartment of Haematology, NHS Blood and Transplant, Cambridge Biomedical Campus Cambridge UKDepartment of Haematology, NHS Blood and Transplant, Cambridge Biomedical Campus Cambridge UKDepartment of Cardiovascular Sciences Centre for Molecular and Vascular Biology, KU Leuven Leuven BelgiumAbstract Background Brain monoamine vesicular transport disease is an infantile onset neurodevelopmental disorder caused by variants in SLC18A2, which codes for the vesicular monoamine transporter 2 (VMAT2) protein, involved in the transport of monoamines into synaptic vesicles and of serotonin into platelet dense granules. Case presentation The presented case is of a child, born of healthy consanguineous parents, who exhibited hypotonia, mental disability, epilepsy, uncontrolled movements, and gastrointestinal problems. A trial treatment with L‐DOPA proved unsuccessful and the exact neurological involvement could not be discerned due to normal metabolic and brain magnetic resonance imaging results. Platelet studies and whole genome sequencing were performed. At age 4, the child's platelets showed a mild aggregation and adenosine triphosphate secretion defect that could be explained by dysmorphic dense granules observed by electron microscopy. Interestingly, the dense granules were almost completely depleted of serotonin. A novel homozygous p.P316A missense variant in VMAT2 was detected in the patient and the consanguineous parents were found to be heterozygous for this variant. Although the presence of VMAT2 on platelet dense granules has been demonstrated before, this is the first report of defective platelet dense granule function related to absent serotonin storage in a patient with VMAT2 deficiency but without obvious clinical bleeding problems. Conclusions This study illustrates the homology between serotonin metabolism in brain and platelets, suggesting that these blood cells can be model cells for some pathways relevant for neurological diseases. The literature on VMAT2 deficiency is reviewed.https://doi.org/10.1002/jmd2.12030epilepsyplatelet dense granulesserotoninvesicular monoamine transporter 2whole genome sequencing
collection DOAJ
language English
format Article
sources DOAJ
author Manisha Padmakumar
Jaak Jaeken
Vincent Ramaekers
Lieven Lagae
Daniel Greene
Chantal Thys
Chris Van Geet
NIHR BioResource
Kathleen Stirrups
Kate Downes
Ernest Turro
Kathleen Freson
spellingShingle Manisha Padmakumar
Jaak Jaeken
Vincent Ramaekers
Lieven Lagae
Daniel Greene
Chantal Thys
Chris Van Geet
NIHR BioResource
Kathleen Stirrups
Kate Downes
Ernest Turro
Kathleen Freson
A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets
JIMD Reports
epilepsy
platelet dense granules
serotonin
vesicular monoamine transporter 2
whole genome sequencing
author_facet Manisha Padmakumar
Jaak Jaeken
Vincent Ramaekers
Lieven Lagae
Daniel Greene
Chantal Thys
Chris Van Geet
NIHR BioResource
Kathleen Stirrups
Kate Downes
Ernest Turro
Kathleen Freson
author_sort Manisha Padmakumar
title A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets
title_short A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets
title_full A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets
title_fullStr A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets
title_full_unstemmed A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets
title_sort novel missense variant in slc18a2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets
publisher Wiley
series JIMD Reports
issn 2192-8312
publishDate 2019-05-01
description Abstract Background Brain monoamine vesicular transport disease is an infantile onset neurodevelopmental disorder caused by variants in SLC18A2, which codes for the vesicular monoamine transporter 2 (VMAT2) protein, involved in the transport of monoamines into synaptic vesicles and of serotonin into platelet dense granules. Case presentation The presented case is of a child, born of healthy consanguineous parents, who exhibited hypotonia, mental disability, epilepsy, uncontrolled movements, and gastrointestinal problems. A trial treatment with L‐DOPA proved unsuccessful and the exact neurological involvement could not be discerned due to normal metabolic and brain magnetic resonance imaging results. Platelet studies and whole genome sequencing were performed. At age 4, the child's platelets showed a mild aggregation and adenosine triphosphate secretion defect that could be explained by dysmorphic dense granules observed by electron microscopy. Interestingly, the dense granules were almost completely depleted of serotonin. A novel homozygous p.P316A missense variant in VMAT2 was detected in the patient and the consanguineous parents were found to be heterozygous for this variant. Although the presence of VMAT2 on platelet dense granules has been demonstrated before, this is the first report of defective platelet dense granule function related to absent serotonin storage in a patient with VMAT2 deficiency but without obvious clinical bleeding problems. Conclusions This study illustrates the homology between serotonin metabolism in brain and platelets, suggesting that these blood cells can be model cells for some pathways relevant for neurological diseases. The literature on VMAT2 deficiency is reviewed.
topic epilepsy
platelet dense granules
serotonin
vesicular monoamine transporter 2
whole genome sequencing
url https://doi.org/10.1002/jmd2.12030
work_keys_str_mv AT manishapadmakumar anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT jaakjaeken anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT vincentramaekers anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT lievenlagae anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT danielgreene anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT chantalthys anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT chrisvangeet anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT nihrbioresource anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT kathleenstirrups anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT katedownes anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT ernestturro anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT kathleenfreson anovelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT manishapadmakumar novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT jaakjaeken novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT vincentramaekers novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT lievenlagae novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT danielgreene novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT chantalthys novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT chrisvangeet novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT nihrbioresource novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT kathleenstirrups novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT katedownes novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT ernestturro novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
AT kathleenfreson novelmissensevariantinslc18a2causesrecessivebrainmonoaminevesiculartransportdiseaseandabsentserotonininplatelets
_version_ 1721356921442664448